-

AHF Keeps Pressure on ‘Greedy Gilead’ Over Price Gouging

HIV/AIDS advocates to protest drug maker at Leerink Partners Biopharma Conference in Miami and call out the poster child for greed – CEO Daniel O’Day – who now is PhRMA board chair

MIAMI--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) advocates will rally at the Fontainebleau Miami Beach Hotel Tuesday to protest Gilead Sciences’ ongoing efforts to rack up exorbitant profits while restricting access to lifesaving medications. AHF’s sustained protests against the drug maker continue as Gilead faces legal action over its keeping safer HIV medications off the market to maximize profits.

It is so sadly apropos that Gilead CEO Daniel O’Day — the poster child for PhRMA greed — also now sits atop PhRMA, the undisputed fortress of greed.

Share

HIV/AIDS activists also will protest Gilead CEO Daniel O’Day over his February appointment as board chair for PhRMA (Pharmaceutical Research and Manufacturers of America), the cutthroat trade group representing companies in the pharmaceutical industry in the United States.

“It is so sadly apropos that Gilead CEO Daniel O’Day — the poster child for PhRMA greed — also now sits atop PhRMA, the undisputed fortress of greed,” said Michael Weinstein, AHF president and cofounder.

Tuesday’s action outside the annual Leerink Partners Biopharma Conference is the latest in a series of escalating efforts by AHF to draw attention to Gilead’s quiet campaign to undermine safety net providers and illegally restrict access to lifesaving HIV and Hepatitis C treatments. Since 2021, AHF has been taking on Gilead and CEO Daniel O’Day, holding more than two dozen protests in multiple cities, including Washington, DC, Miami, Boston, and Foster City, CA at Gilead’s corporate headquarters.

WHO:

AHF Advocates and Allies

WHEN:

Tuesday, March 12, 2024 at 10:00 a.m. ET

WHERE:

Fontainebleau Miami Beach (Leerink Partners Global Biopharma Conference)

 

4441 Collins Ave, Miami Beach, FL 33140

AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS healthcare organization, provides cutting-edge medicine and advocacy to more than 1.9 million individuals across 45 countries, including the U.S. and in Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, visit us online at AIDShealth.org, find us on Facebook, follow us on Instagram, Twitter, and TikTok, and subscribe to our AHFter Hours podcast.

Contacts

John Farina, AHF Associate Director of Advocacy
(216) 832-7106 c
john.farina@ahf.org

Ged Kenslea, Senior Director, Communications, AHF
+1.323.791.5526 [cell]
gedk@aidshealth.org

AIDS Healthcare Foundation


Release Summary
AHF Keeps Pressure on ‘Greedy Gilead’ Over Price Gouging
Release Versions

Contacts

John Farina, AHF Associate Director of Advocacy
(216) 832-7106 c
john.farina@ahf.org

Ged Kenslea, Senior Director, Communications, AHF
+1.323.791.5526 [cell]
gedk@aidshealth.org

More News From AIDS Healthcare Foundation

AHF Hails Introduction of Protect 340B Act of 2026

WASHINGTON--(BUSINESS WIRE)--AHF Hails Introduction of Protect 340B Act of 2026...

AHF Urges African Nations to Take Charge of Medicines Regulation

KIGALI, Rwanda--(BUSINESS WIRE)--With more than 20 African Union Member States yet to ratify the African Medicines Agency (AMA) Treaty, AIDS Healthcare Foundation (AHF) calls on African governments to accelerate ratification and regulatory harmonisation to expand access to affordable medicines and unlock Africa’s pharmaceutical manufacturing potential.The call comes as AMA convenes its inaugural week in Kigali, Rwanda, from 25–30 October 2026, against a backdrop of continued dependence on import...

Treatment = Life: AHF Reaches 2 Million Patients in Care in Africa

KAMPALA, Uganda--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) has surpassed 2 million patients in care across 15 African countries, marking a historic achievement 25 years after beginning its first programs outside the United States in South Africa and Uganda. With programs in four additional countries expected to launch in 2027, AHF is recognizing the communities and partnerships behind this progress while calling for urgent action to close persistent gaps in the HIV response. AHF’s work...
Back to Newsroom